Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Mercure Hotel Amsterdam City

04 dic 2019 8:00 a.m. - 05 dic 2019 5:00 p.m.

Joan Muyskenweg 10, 1096 CJ Amsterdam, Netherlands

Clinical Trial Disclosure & Data Transparency Conference

Evolving Requirements and New Challenges

Session 8: GDPR

Session Chair(s)

Scott  Feiner

Scott Feiner

Senior Manager, Trial Disclosure

AbbVie, United States

Practical strategies for implementing GDPR across the product development lifecycle. While sponsors are gaining experience in protecting individual privacy in Policy 0070 and Health Canada submissions, the CTIS and Eudamed databases will provide a public window to a sponsor’s entire product development lifecycle. New reidentification techniques can jeopardize existing practices in anonymization, while additional privacy regulations, such as the California Consumer Privacy Act, will place new obligations on Sponsors. This session explores these challenges and discusses practical approaches to fulfilling the requirements of the GDPR and individual privacy protection. Nature Identification Article Estimating the success of re-identifications in incomplete datasets using generative models – Luc Rocher, Julien M. Hendrickx & Yves-Alexander de Montjoye

Speaker(s)

Hannah  Crowther

Overall Challenge in Implementing GDPR in the Lifecycle of a Product

Hannah Crowther

Bristows LLP, United Kingdom

Senior Associate

Loes  Markenstein

GDPR

Loes Markenstein

Dutch Data Protection Authority, Netherlands

Senior Inspector

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.